尤比基特异蛋白酶25通过调节-STAT3的降解来改善性结肠炎
Zhengru Liu1,2, Jian Liu1, Yuping Wei3
1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Cell death & disease
|January 8, 2025
概括
乌比基特异性蛋白酶25 (USP25) 缺乏通过破坏肠道屏障,使性结肠炎 (UC) 恶化. USP25通过稳定-STAT3,提供潜在的治疗点来保护UC.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 乌比基特异蛋白酶25 (USP25) 在UC病变发生过程中的作用尚不清楚.
- USP25参与蛋白质无处不在,降解,炎症和免疫调节.
研究的目的:
- 研究USP25在性结肠炎 (UC) 中的作用和机制.
- 确定USP25是否可以成为UC的治疗点.
主要方法:
- 在UC患者中进行生物信息学分析.
- 使用 Usp25 淘汰赛小鼠和硫酸 (DSS) 诱导的大肠炎模型的研究.
- 对肠道上皮细胞特异性的Stat3敲击小鼠的分析.
- 在人结肠上皮细胞的体外研究.
主要成果:
- 在UC患者和DSS诱导的大肠炎小鼠中,USP25的表达减少.
- USP25缺乏症通过损害肠道粘膜屏障而加剧UC.
- USP25过度表达可以缓解结肠炎.
- USP25通过准K48链接的ubiquitination. deubiquitinates和稳定Y705上的-STAT3.
- 在USP25淘汰赛小鼠中,STAT3缺乏会加剧DSS诱导的大肠炎,而STAT3过度表达会减轻大肠炎.
结论:
- USP25通过调节-STAT3降解来改善UC.
- USP25作为一个特定的STAT3调节器.
- USP25代表了UC的潜在治疗目标.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Inflammatory Bowel Disease V: Surgical Management
116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
116
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
353
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
353
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110


